共 448 条
[1]
D'Amico A(2011)Spinal muscular atrophy Orphanet J Rare Dis 6 71-1732
[2]
Mercuri E(2017)Nusinersen versus sham control in infantile-onset spinal muscular atrophy N Engl J Med 377 1723-635
[3]
Tiziano FD(2018)Nusinersen versus sham control in later-onset spinal muscular atrophy N Engl J Med 378 625-923
[4]
Bertini E(2021)Risdiplam in type 1 spinal muscular atrophy N Engl J Med 384 915-1722
[5]
Mendell JR(2017)Single-dose gene-replacement therapy for spinal muscular atrophy N Engl J Med 377 1713-325
[6]
Al-Zaidy S(2020)Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study Lancet Neurol 19 317-127
[7]
Shell R(2018)Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1 Eur J Paediatr Neurol 22 122-e1318
[8]
Arnold WD(2018)Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: a cohort study Neurology 91 e1312-42
[9]
Rodino-Klapac LR(2020)Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: real world data from Hungarian patients Eur J Paediatr Neurol 27 37-771
[10]
Prior TW(2020)Gain and loss of abilities in type II SMA: a 12-month natural history study Neuromuscul Disord 30 765-1117